Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correlation of free IgE with clinical parameters in asthma patients treated with omalizumab
2009-012108-15Phase 4Completed
- Sponsor
- University Medical Center Mainz
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of omalizumab in asthma, sponsored by University Medical Center Mainz. Primary endpoint: Asthma control as a function of levels of free IgE. Started Apr 2009; status: completed.
02
Drugs
omalizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-012108-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012108-15.